Model‐based risk analysis of coupled process steps
暂无分享,去创建一个
Karin Westerberg | Bernt Nilsson | Ernst Broberg-Hansen | Lars Sejergaard | B. Nilsson | Karin Westerberg | Lars Sejergaard | Ernst Broberg-Hansen
[1] D Petrides,et al. Computer-aided process analysis and economic evaluation for biosynthetic human insulin production-A case study. , 1995, Biotechnology and bioengineering.
[2] Hervé Broly,et al. Application of the quality by design approach to the drug substance manufacturing process of an Fc fusion protein: towards a global multi-step design space. , 2012, Journal of pharmaceutical sciences.
[3] Sunil Chhatre,et al. Global sensitivity analysis for the determination of parameter importance in the chromatographic purification of polyclonal antibodies , 2008 .
[4] J A Asenjo,et al. Application of chromatographic theory for process characterization towards validation of an ion‐exchange operation , 2007, Biotechnology and bioengineering.
[5] Karin Westerberg,et al. Model‐Based Process Challenge of an Industrial Ion‐Exchange Chromatography Step , 2012 .
[6] Sunil Chhatre,et al. Global Sensitivity Analysis for the determination of parameter importance in bio‐manufacturing processes , 2008, Biotechnology and applied biochemistry.
[7] Giancarlo Tonon,et al. Enzymatic techniques for PEGylation of biopharmaceuticals , 2009 .
[8] N. J. Titchener-Hooker,et al. The use of windows of operation as a bioprocess design tool , 1996 .
[9] Anita M. Katti,et al. Fundamentals of Preparative and Nonlinear Chromatography , 1994 .
[10] V. S. Vaidhyanathan,et al. Transport phenomena , 2005, Experientia.
[11] Y H Zhou,et al. Visualizing integrated bioprocess designs through "windows of operation". , 1999, Biotechnology and bioengineering.
[12] Anurag S Rathore,et al. Roadmap for implementation of quality by design (QbD) for biotechnology products. , 2009, Trends in biotechnology.
[13] Marcel Ottens,et al. Design strategies for integrated protein purification processes: challenges, progress and outlook , 2008 .
[14] F. Veronese,et al. PEGylated Protein Drugs: Basic Science and Clinical Applications , 2009 .
[15] Patrick Thompson,et al. Defining process design space for monoclonal antibody cell culture , 2010, Biotechnology and bioengineering.
[16] Tingyue Gu,et al. Mathematical modeling and scale-up of size-exclusion chromatography , 1998 .
[17] A. Rathore,et al. Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.
[18] Cameron Alexander,et al. Synthetic polymers for biopharmaceutical delivery , 2011 .